Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.070
+0.100 (5.08%)
At close: Jan 8, 2026, 4:00 PM EST
2.070
0.00 (0.00%)
After-hours: Jan 8, 2026, 4:00 PM EST
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $29.58 million as of January 8, 2026. Its market cap has increased by 14.20% in one year.
Market Cap
29.58M
Enterprise Value
8.88M
1-Year Change
14.20%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $29.58M, a decrease of -69.82%. That is a compound annual growth rate of -9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 28.10M | 1.81% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |